(Q34936238)

5 August 2017

1 reference

title

Hepatitis B: progress in the last 15 years (English)

1 reference

5 August 2017

1 reference

Federico G Villamil

1

1 reference

5 August 2017

1 October 2002

1 reference

5 August 2017

Liver Transplantation

1 reference

5 August 2017

8

1 reference

5 August 2017

10 Suppl 1

1 reference

5 August 2017

S59-66

1 reference

Liver transplantation (2).

5 August 2017

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Delayed respiratory depression after use of fentanyl during anaesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Liver transplantation in hepatitis delta virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Laparoscopic study of peliosis hepatis and nodular transformation of the liver before and after renal transplantation: natural history and aetiology in follow-up cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Retransplantation of patients with severe posttransplant hepatitis B in the first allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Lamivudine treatment for acute hepatitis B after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35782

21 January 2018

Identifiers

DOI

10.1053/JLTS.2002.35782

1 reference

5 August 2017

1 reference

PubMed ID

12362301